Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants-Reference-Cited by-同舟云学术

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

Published:2003-07 Issue:23 Volume:21 Page:3265-3272
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jódar Luis,Butler Jay,Carlone George,Dagan Ron,Goldblatt David,Käyhty Helena,Klugman Keith,Plikaytis Brian,Siber George,Kohberger Robert,Chang Ih,Cherian Thomas

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec 1999;74:177–83.

2. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Preventing pneumococcal disease among infants and young children. MMWR 2000;49(RR09):1–38.

3. Efficacy safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group;Black;Pediatr. Infect. Dis. J.,2000

4. Which pneumococcal serogroups cause the most invasive disease. Part I. Implications for conjugate vaccine formulation and use;Hausdorff;Clin. Infect. Dis.,2000

5. Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants;Puumalainen;Pediatr. Infect. Dis. J.,2002

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling conjugate vaccine and natural induced antibody correlates of protection for pneumococcal colonization and acute otitis media infection in young children;Vaccine;2024-12

2. Biological puzzles solved by using Streptococcus pneumoniae : a historical review of the pneumococcal studies that have impacted medicine and shaped molecular bacteriology;Journal of Bacteriology;2024-06-20

3. Realising the potential of correlates of protection for vaccine development, licensure and use: short summary;npj Vaccines;2024-04-29

4. Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides;Human Vaccines & Immunotherapeutics;2024-04-12

5. Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen;Expert Review of Vaccines;2024-04-09